http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2537103-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcb9b9a0288c639a2fa6c69dd7514f7f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4747
filingDate 2004-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7bc1ddd0e193743d2092d7ef6bcfda6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c72db25897b85da678f19e2fac99b772
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_411b66fdbd71d684209b14bb0a605ddf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aff602cd68a6160c7486bd3222eb1c7e
publicationDate 2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2537103-A1
titleOfInvention Once daily dosage forms of trospium
abstract A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9974752-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10500162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10688060-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10507186-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512612-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10512613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10292938-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10292939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10722473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449159-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10111839-B2
priorityDate 2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034812
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452510107

Total number of triples: 50.